Literature DB >> 12797466

The role of oxidative stress in diabetic vascular and neural disease.

Mark A Yorek1.   

Abstract

This review will focus on the impact of hyperglycemia-induced oxidative stress in the development of diabetes-induced vascular and neural dysfunction. Oxidative stress occurs when the balance between the production of oxidation products and the ability of antioxidant mechanisms to neutralize these products is tilted in the favor of the former. The production of reactive oxygen species has been shown to be increased in patients with diabetes. The possible sources for the overproduction of reactive oxygen species is widespread and include enzymatic pathways, autoxidation of glucose and the mitochondria. Increase in oxidative stress has clearly been shown to contribute to the pathology of vascular disease not only in diabetes but also in hypertension, stroke and ischemia. Since the etiology of diabetic neuropathy is considered to have a large vascular component, prevention of oxidative stress in diabetes is considered by many investigators to be a primary defense against the development of diabetic vascular disease. Potential therapies for preventing increased oxidative stress in diabetes and the neural vasculature will be discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12797466     DOI: 10.1080/1071576031000083161

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  49 in total

Review 1.  New insights into the mechanisms of diabetic neuropathy.

Authors:  Andrea M Vincent; Eva L Feldman
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  Mitochondrial stress and the pathogenesis of diabetic neuropathy.

Authors:  Paul Fernyhough; Subir K Roy Chowdhury; Robert E Schmidt
Journal:  Expert Rev Endocrinol Metab       Date:  2010-01-01

3.  Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy.

Authors:  Roman Stavniichuk; Hanna Shevalye; Sergey Lupachyk; Alexander Obrosov; John T Groves; Irina G Obrosova; Mark A Yorek
Journal:  Diabetes Metab Res Rev       Date:  2014-11       Impact factor: 4.876

4.  Effect of mitoquinone (Mito-Q) on neuropathic endpoints in an obese and type 2 diabetic rat model.

Authors:  Brian Fink; Lawrence Coppey; Eric Davidson; Hanna Shevalye; Alexander Obrosov; Pratik Rajesh Chheda; Robert Kerns; William Sivitz; Mark Yorek
Journal:  Free Radic Res       Date:  2020-04-24

5.  The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy.

Authors:  Eric Davidson; Lawrence Coppey; Bao Lu; Victor Arballo; Nigel A Calcutt; Craig Gerard; Mark Yorek
Journal:  Exp Diabetes Res       Date:  2010-02-03

6.  Nitric oxide consumption through lipid peroxidation in brain cell suspensions and homogenates.

Authors:  Robert G Keynes; Charmaine H Griffiths; Catherine Hall; John Garthwaite
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

7.  Insulin promotes survival of amyloid-beta oligomers neuroblastoma damaged cells via caspase 9 inhibition and Hsp70 upregulation.

Authors:  M Di Carlo; P Picone; R Carrotta; D Giacomazza; P L San Biagio
Journal:  J Biomed Biotechnol       Date:  2010-05-13

8.  Impact of exercise training on oxidative stress in individuals with a spinal cord injury.

Authors:  Noortje van Duijnhoven; Evelyne Hesse; Thomas Janssen; Will Wodzig; Peter Scheffer; Maria Hopman
Journal:  Eur J Appl Physiol       Date:  2010-04-03       Impact factor: 3.078

9.  Ultra-low microcurrent in the management of diabetes mellitus, hypertension and chronic wounds: report of twelve cases and discussion of mechanism of action.

Authors:  Bok Y Lee; Noori Al-Waili; Dean Stubbs; Keith Wendell; Glenn Butler; Thia Al-Waili; Ali Al-Waili
Journal:  Int J Med Sci       Date:  2009-12-06       Impact factor: 3.738

10.  Mitochondrial respiratory chain dysfunction in dorsal root ganglia of streptozotocin-induced diabetic rats and its correction by insulin treatment.

Authors:  Subir K Roy Chowdhury; Elena Zherebitskaya; Darrell R Smith; Eli Akude; Sharmila Chattopadhyay; Corinne G Jolivalt; Nigel A Calcutt; Paul Fernyhough
Journal:  Diabetes       Date:  2010-01-26       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.